The inflammatory protein Pentraxin 3 in cardiovascular disease

Francesco Fornai, Albino Carrizzo, Maurizio Forte, Mariateresa Ambrosio, Antonio Damato, Michela Ferrucci, Francesca Biagioni, Carla Letizia Busceti, Annibale Alessandro Puca, Carmine Vecchione

Research output: Contribution to journalArticle

Abstract

The acute phase protein Pentraxin 3 (PTX3) plays a non-redundant role as a soluble pattern recognition receptor for selected pathogens and it represents a rapid biomarker for primary local activation of innate immunity and inflammation. Recent evidence indicates that PTX3 exerts an important role in modulating the cardiovascular system in humans and experimental models. In particular, there are conflicting points concerning the effects of PTX3 in cardiovascular diseases (CVD) since several observations indicate a cardiovascular protective effect of PTX3 while others speculate that the increased plasma levels of PTX3 in subjects with CVD correlate with disease severity and with poor prognosis in elderly patients. In the present review, we discuss the multifaceted effects of PTX3 on the cardiovascular system focusing on its involvement in atherosclerosis, endothelial function, hypertension, myocardial infarction and angiogenesis. This may help to explain how the specific modulation of PTX3 such as the use of different dosing, time, and target organs could help to contain different vascular diseases. These opposite actions of PTX3 will be emphasized concerning the modulation of cardiovascular system where potential therapeutic implications of PTX3 in humans are discussed.

Original languageEnglish
Article number25
JournalImmunity and Ageing
Volume13
Issue number1
DOIs
Publication statusPublished - Aug 24 2016

Fingerprint

Cardiovascular Diseases
Proteins
Cardiovascular System
Pattern Recognition Receptors
PTX3 protein
Acute-Phase Proteins
Vascular Diseases
Innate Immunity
Atherosclerosis
Theoretical Models
Biomarkers
Myocardial Infarction
Hypertension
Inflammation

Keywords

  • Acute phase protein of inflammation
  • Angiogenesis
  • Atherosclerosis
  • Cardiovascular diseases
  • Myocardial infarction
  • Pentraxin 3

ASJC Scopus subject areas

  • Immunology
  • Ageing

Cite this

Fornai, F., Carrizzo, A., Forte, M., Ambrosio, M., Damato, A., Ferrucci, M., ... Vecchione, C. (2016). The inflammatory protein Pentraxin 3 in cardiovascular disease. Immunity and Ageing, 13(1), [25]. https://doi.org/10.1186/s12979-016-0080-1

The inflammatory protein Pentraxin 3 in cardiovascular disease. / Fornai, Francesco; Carrizzo, Albino; Forte, Maurizio; Ambrosio, Mariateresa; Damato, Antonio; Ferrucci, Michela; Biagioni, Francesca; Busceti, Carla Letizia; Puca, Annibale Alessandro; Vecchione, Carmine.

In: Immunity and Ageing, Vol. 13, No. 1, 25, 24.08.2016.

Research output: Contribution to journalArticle

Fornai, F, Carrizzo, A, Forte, M, Ambrosio, M, Damato, A, Ferrucci, M, Biagioni, F, Busceti, CL, Puca, AA & Vecchione, C 2016, 'The inflammatory protein Pentraxin 3 in cardiovascular disease', Immunity and Ageing, vol. 13, no. 1, 25. https://doi.org/10.1186/s12979-016-0080-1
Fornai F, Carrizzo A, Forte M, Ambrosio M, Damato A, Ferrucci M et al. The inflammatory protein Pentraxin 3 in cardiovascular disease. Immunity and Ageing. 2016 Aug 24;13(1). 25. https://doi.org/10.1186/s12979-016-0080-1
Fornai, Francesco ; Carrizzo, Albino ; Forte, Maurizio ; Ambrosio, Mariateresa ; Damato, Antonio ; Ferrucci, Michela ; Biagioni, Francesca ; Busceti, Carla Letizia ; Puca, Annibale Alessandro ; Vecchione, Carmine. / The inflammatory protein Pentraxin 3 in cardiovascular disease. In: Immunity and Ageing. 2016 ; Vol. 13, No. 1.
@article{37bb46e1b4584b6e809c0e2d2df358ec,
title = "The inflammatory protein Pentraxin 3 in cardiovascular disease",
abstract = "The acute phase protein Pentraxin 3 (PTX3) plays a non-redundant role as a soluble pattern recognition receptor for selected pathogens and it represents a rapid biomarker for primary local activation of innate immunity and inflammation. Recent evidence indicates that PTX3 exerts an important role in modulating the cardiovascular system in humans and experimental models. In particular, there are conflicting points concerning the effects of PTX3 in cardiovascular diseases (CVD) since several observations indicate a cardiovascular protective effect of PTX3 while others speculate that the increased plasma levels of PTX3 in subjects with CVD correlate with disease severity and with poor prognosis in elderly patients. In the present review, we discuss the multifaceted effects of PTX3 on the cardiovascular system focusing on its involvement in atherosclerosis, endothelial function, hypertension, myocardial infarction and angiogenesis. This may help to explain how the specific modulation of PTX3 such as the use of different dosing, time, and target organs could help to contain different vascular diseases. These opposite actions of PTX3 will be emphasized concerning the modulation of cardiovascular system where potential therapeutic implications of PTX3 in humans are discussed.",
keywords = "Acute phase protein of inflammation, Angiogenesis, Atherosclerosis, Cardiovascular diseases, Myocardial infarction, Pentraxin 3",
author = "Francesco Fornai and Albino Carrizzo and Maurizio Forte and Mariateresa Ambrosio and Antonio Damato and Michela Ferrucci and Francesca Biagioni and Busceti, {Carla Letizia} and Puca, {Annibale Alessandro} and Carmine Vecchione",
year = "2016",
month = "8",
day = "24",
doi = "10.1186/s12979-016-0080-1",
language = "English",
volume = "13",
journal = "Immunity and Ageing",
issn = "1742-4933",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The inflammatory protein Pentraxin 3 in cardiovascular disease

AU - Fornai, Francesco

AU - Carrizzo, Albino

AU - Forte, Maurizio

AU - Ambrosio, Mariateresa

AU - Damato, Antonio

AU - Ferrucci, Michela

AU - Biagioni, Francesca

AU - Busceti, Carla Letizia

AU - Puca, Annibale Alessandro

AU - Vecchione, Carmine

PY - 2016/8/24

Y1 - 2016/8/24

N2 - The acute phase protein Pentraxin 3 (PTX3) plays a non-redundant role as a soluble pattern recognition receptor for selected pathogens and it represents a rapid biomarker for primary local activation of innate immunity and inflammation. Recent evidence indicates that PTX3 exerts an important role in modulating the cardiovascular system in humans and experimental models. In particular, there are conflicting points concerning the effects of PTX3 in cardiovascular diseases (CVD) since several observations indicate a cardiovascular protective effect of PTX3 while others speculate that the increased plasma levels of PTX3 in subjects with CVD correlate with disease severity and with poor prognosis in elderly patients. In the present review, we discuss the multifaceted effects of PTX3 on the cardiovascular system focusing on its involvement in atherosclerosis, endothelial function, hypertension, myocardial infarction and angiogenesis. This may help to explain how the specific modulation of PTX3 such as the use of different dosing, time, and target organs could help to contain different vascular diseases. These opposite actions of PTX3 will be emphasized concerning the modulation of cardiovascular system where potential therapeutic implications of PTX3 in humans are discussed.

AB - The acute phase protein Pentraxin 3 (PTX3) plays a non-redundant role as a soluble pattern recognition receptor for selected pathogens and it represents a rapid biomarker for primary local activation of innate immunity and inflammation. Recent evidence indicates that PTX3 exerts an important role in modulating the cardiovascular system in humans and experimental models. In particular, there are conflicting points concerning the effects of PTX3 in cardiovascular diseases (CVD) since several observations indicate a cardiovascular protective effect of PTX3 while others speculate that the increased plasma levels of PTX3 in subjects with CVD correlate with disease severity and with poor prognosis in elderly patients. In the present review, we discuss the multifaceted effects of PTX3 on the cardiovascular system focusing on its involvement in atherosclerosis, endothelial function, hypertension, myocardial infarction and angiogenesis. This may help to explain how the specific modulation of PTX3 such as the use of different dosing, time, and target organs could help to contain different vascular diseases. These opposite actions of PTX3 will be emphasized concerning the modulation of cardiovascular system where potential therapeutic implications of PTX3 in humans are discussed.

KW - Acute phase protein of inflammation

KW - Angiogenesis

KW - Atherosclerosis

KW - Cardiovascular diseases

KW - Myocardial infarction

KW - Pentraxin 3

UR - http://www.scopus.com/inward/record.url?scp=84983233502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983233502&partnerID=8YFLogxK

U2 - 10.1186/s12979-016-0080-1

DO - 10.1186/s12979-016-0080-1

M3 - Article

VL - 13

JO - Immunity and Ageing

JF - Immunity and Ageing

SN - 1742-4933

IS - 1

M1 - 25

ER -